CVSA on XNYS, Services, Covista Inc., job postings
Measures activity, not value. Not investment advice.
Quarterly revenue rose 11% to $511.5M while capital spending jumped 135% to $37.6M.
BadShort interest 8.5% of shares, 8.2 days to cover
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.
expected around 27 Jan 2027 (an estimate: a year ago it reported on 28 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $511.5M, net income $67.4M.
31 Dec 2021RevenueNet incometallest bar $511.5M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$511.5M
$67.4M
30 Jun 2026
$501.4M
$71.7M
31 Mar 2026
$487.0M
$41.6M
31 Dec 2025
$503.4M
$76.4M
30 Sep 2025
$462.3M
$61.8M
30 Jun 2025
$457.1M
$54.2M
31 Mar 2025
$466.1M
$60.8M
31 Dec 2024
$447.7M
$75.9M
30 Sep 2024
$417.4M
$46.2M
30 Jun 2024
$409.9M
–
31 Mar 2024
$412.7M
$36.8M
31 Dec 2023
$393.2M
$39.9M
30 Sep 2023
$368.8M
$10.6M
31 Mar 2023
$369.1M
$45.9M
31 Dec 2022
$363.3M
$24.1M
30 Sep 2022
$354.6M
$2.2M
30 Jun 2022
$361.2M
$8.0M
31 Mar 2022
$365.6M
$349.8M
31 Dec 2021
$371.2M
$17.9M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$2.0B
$1.8B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+9.3%
+2.9%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$257.2M
$252.7M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$7.31
$6.68
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
57.4%
57.1%
56.2%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
19.8%
19.5%
9.2%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
12.8%
13.8%
6.8%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
17.9%
15.8%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$354.6M
$323.2M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$222.2M
$264.7M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$500.2M
$553.2M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$278.0M
$288.5M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.35
0.21
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$42.75
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
14.1
12.9
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
1.8
1.1
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
2.0
1.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
2.6
2.1
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+11%
$511.5M vs $462.3M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+135%
$37.6M vs $16.0M (quarter ended 30 Sep 2026)
Insider buy/sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$1.3M
bought $0, sold $1.3M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+4.3%
385 13F filers vs 369
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
over 100%
33.9M shares held by 13F filers (30 Sep 2026) of 33.3M outstanding (23 Oct 2026); above 100%: the share count is probably stale
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
8.5%
2.8M shares sold short (30 Oct 2026) of 33.3M outstanding (23 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
8.2
2.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+1.4%
2.8M shares sold short in the report before, 2.8M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
83%
83% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 63%
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$42K
the 12 months before: $28K
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$740K
4 quarters
News iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
10
10 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
10×
10 articles in the last 7 days; its usual week has 1.
Unusual now sharp changes in the last 90 days, compared with its own past
Capital spending $37.6M, 2.3× a year earlier
Price $109.13 on 20 Nov 2026, +9.6% over 12 months (12-month range $96.07 to $140.98)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders sold a net $6.6M in the last 12 months (the 12 months before: -$9.7M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 8 published in the last 12 months (none in the 12 months before).Revenue per quarter. Revenue $511.5M in the latest quarter, +11% on a year earlier.Capital spending per quarter. Capital spending $37.6M in the latest quarter, +135% on a year earlier.Institutional holders (13F filers). 385 13F filers reported holding it in the latest 13F quarter, +1.3% on a year earlier.Federal obligations. Federal obligations: $68K published in the last 12 months, +37% on the 12 months before.Lobbying spend. Lobbying spend: $740K published in the last 12 months, -53% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.
Quarter ended 30 Jun 2021: $223.5M; public on 12 Aug 2022
Quarter ended 31 Dec 2021: $371.2M, +31% on a year earlier; public on 9 Feb 2022
Quarter ended 31 Mar 2022: $365.6M, +30% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $361.2M, +62% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $354.6M, +1.8% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $363.3M, -2.1% on a year earlier; public on 3 Feb 2023
Quarter ended 31 Mar 2023: $369.1M, +0.9% on a year earlier; public on 3 May 2023
Quarter ended 30 Sep 2023: $368.8M, +4.0% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $393.2M, +8.2% on a year earlier; public on 31 Jan 2024
Quarter ended 31 Mar 2024: $412.7M, +12% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $409.9M; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $417.4M, +13% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $447.7M, +14% on a year earlier; public on 31 Jan 2025
Quarter ended 31 Mar 2025: $466.1M, +13% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $457.1M, +12% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $462.3M, +11% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $503.4M, +12% on a year earlier; public on 29 Jan 2026
Quarter ended 31 Mar 2026: $487.0M, +4.5% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $501.4M, +9.7% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $511.5M, +11% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $8.1M, -17% on a year earlier; public on 9 Feb 2022
Quarter ended 31 Mar 2022: $7.5M, -30% on a year earlier; public on 6 May 2022
Quarter ended 30 Sep 2022: $5.6M, -24% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $4.2M, -48% on a year earlier; public on 3 Feb 2023
Quarter ended 31 Mar 2023: $9.3M, +25% on a year earlier; public on 3 May 2023
Quarter ended 30 Sep 2023: $15.0M, +171% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $15.3M, +264% on a year earlier; public on 31 Jan 2024
Quarter ended 31 Mar 2024: $21.7M, +133% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $16.6M; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $10.4M, -31% on a year earlier; public on 30 Oct 2024
Quarter ended 30 Sep 2025: $16.0M, +54% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $14.6M; public on 29 Jan 2026
Quarter ended 31 Mar 2026: $20.2M; public on 8 May 2026
Quarter ended 30 Jun 2026: $26.8M; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $37.6M, +135% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 156; public on 14 Feb 2022
31 Mar 2022 report: 161; public on 16 May 2022
30 Jun 2022 report: 187; public on 15 Aug 2022
30 Sep 2022 report: 160; public on 14 Nov 2022
31 Dec 2022 report: 191; public on 14 Feb 2023
31 Mar 2023 report: 180; public on 15 May 2023
30 Jun 2023 report: 181; public on 14 Aug 2023
30 Sep 2023 report: 191; public on 14 Nov 2023
31 Dec 2023 report: 228; public on 14 Feb 2024
31 Mar 2024 report: 231; public on 15 May 2024
30 Jun 2024 report: 248; public on 14 Aug 2024
30 Sep 2024 report: 260; public on 14 Nov 2024
31 Dec 2024 report: 304; public on 14 Feb 2025
31 Mar 2025 report: 324; public on 15 May 2025
30 Jun 2025 report: 367; public on 14 Aug 2025
30 Sep 2025 report: 380; public on 14 Nov 2025
31 Dec 2025 report: 353; public on 17 Feb 2026
31 Mar 2026 report: 343; public on 15 May 2026
30 Jun 2026 report: 369; public on 14 Aug 2026
30 Sep 2026 report: 385; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $123K published
Month from 1 Jan 2022: $14K published
Month from 1 Feb 2022: $18K published
Month from 1 Mar 2022: $10K published
Month from 1 Apr 2022: $31K published
Month from 1 May 2022: $245K published
Month from 1 Jun 2022: $52K published
Month from 1 Jul 2022: $1.4M published
Month from 1 Aug 2022: $65K published
Month from 1 Sep 2022: $430K published
Month from 1 Nov 2022: $92K published
Month from 1 Dec 2022: $134K published
Month from 1 Feb 2023: $56K published
Month from 1 Mar 2023: $18K published
Month from 1 May 2023: $254K published
Month from 1 Jun 2023: $13K published
Month from 1 Jul 2023: $331K published
Month from 1 Sep 2023: $86K published
Month from 1 Nov 2023: $16K published
Month from 1 Dec 2023: $24K published
Month from 1 Mar 2024: $11K published
Month from 1 Apr 2024: $15K published
Month from 1 Jun 2024: $1.2M published
Month from 1 Jul 2024: $0 published
Month from 1 Oct 2024: $0 published
Month from 1 Nov 2024: $0 published
Month from 1 Mar 2025: $11K published
Month from 1 Apr 2025: $15K published
Month from 1 Jun 2025: $2K published
Month from 1 Aug 2025: $0 published
Month from 1 Sep 2025: $21K published
Month from 1 Dec 2025: $14K published
Month from 1 Mar 2026: -$11K published
Month from 1 Apr 2026: $15K published
Month from 1 May 2026: $0 published
Month from 1 Jun 2026: $2K published
Month from 1 Sep 2026: $14K published
Month from 1 Oct 2026: $34K published
Month from 1 Nov 2026: $0 published
Lobbying spend
Quarter from 1 Jan 2022: $120K published
Quarter from 1 Apr 2022: $110K published
Quarter from 1 Jul 2022: $100K published
Quarter from 1 Oct 2022: $120K published
Quarter from 1 Jan 2023: $90K published
Quarter from 1 Apr 2023: $60K published
Quarter from 1 Jul 2023: $50K published
Quarter from 1 Oct 2023: $300K published
Quarter from 1 Jan 2024: $150K published
Quarter from 1 Apr 2024: $150K published
Quarter from 1 Jul 2024: $140K published
Quarter from 1 Oct 2024: $530K published
Quarter from 1 Jan 2025: $170K published
Quarter from 1 Apr 2025: $160K published
Quarter from 1 Jul 2025: $310K published
Quarter from 1 Oct 2025: $950K published
Quarter from 1 Jan 2026: $240K published
Quarter from 1 Apr 2026: $220K published
Quarter from 1 Jul 2026: $160K published
Quarter from 1 Oct 2026: $120K published
What is unusual now
Made public in the last 90 days: it spent $37.6M on capital projects in the quarter ended 30 Sep 2026, 2.3× the same quarter last year.
Quarterly capital spending jump: spent $37.6M on capital projects in the quarter ended 30 Sep 2026, 2.3× the same quarter last year Public on 3 Nov 2026.
Reported lobbying spend: $120K in Q3 2026, $160K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
14 Jun 2026
Ended
Alpine Group Partners, LLC.for Covista
Education, student loans, Department of Education, medical workforce shortageEducation, Labor, Health issues
Two or more unrelated kinds of records unusual within 30 days
13 Nov 2021confirmed
Confirmed across sources Insiders and Lobbying
Covista(CVSA): reported $320K of lobbying spend for the quarter ended 30 Sep 2021, 2.7× the same quarter last year, while it had 3 insiders buy $744K of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 17 days.
Lobbying: Lobbying spend jump, became public on 20 Oct 2021
Insiders: Clustered insider buying, became public on 13 Nov 2021
The quarter ended 30 Sep 2021 against the 8 quarters before it.
this quarterearliernormal: $105KSee the evidence (2 changes)
Lobbying: Lobbying spend jump became public on 20 Oct 2021
Covista reported $320K of lobbying spend for the quarter ended 30 Sep 2021, 2.7× the same quarter last year.
This period
$320K (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
$105K
Typical spread (median absolute deviation)
$10K
How far from its usual level
+10.8
Same quarter last year
$120K
History used
3,105 days
the quarter ended 30 Sep 20218 earlier quartersnormal: $105K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
20 Jul 2021confirmed
Confirmed across sources Government contracts and Lobbying
Covista(CVSA): lobbying on a new issue, while it booked $5.8M in federal contract and grant obligations in June 2021, 23% below the same month last year. Two unrelated kinds of activity on the same day.
Lobbying: Lobbying on a new issue, became public on 20 Jul 2021
Government contracts: Federal obligations jump, became public on 15 Jul 2021
June 2021 against the 5 months before it.
this monthearliernormal: $19KSee the evidence (2 changes)
Lobbying: Lobbying on a new issue became public on 20 Jul 2021
Covista lobbying on a new issue.
New
['TAX']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12638687
Government contracts: Federal obligations jump became public on 15 Jul 2021
Covista booked $5.8M in federal contract and grant obligations in June 2021, 23% below the same month last year.
This period
$5.8M (June 2021)
Normal month (median of 5 earlier)
$19K
Typical spread (median absolute deviation)
$19K
How far from its usual level
+5.8
Same month last year
$7.6M
History used
5,020 days
June 20215 earlier monthsnormal: $19K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
3 Nov 2026Financials change
spent $37.6M on capital projects in the quarter ended 30 Sep 2026, 2.3× the same quarter last year.
Same quarter last year: $16.0M; its normal quarter is $16.3M.
See the evidence
This period
$37.6M (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
$16.3M
Typical spread (median absolute deviation)
$2.8M
How far from its usual level
+5.1
Same quarter last year
$16.0M
History used
6,209 days
the quarter ended 30 Sep 20268 earlier quartersnormal: $16.3M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
reported $530K of lobbying spend for the quarter ended 30 Sep 2024, 1.8× the same quarter last year.
Same quarter last year: $300K; its normal quarter is $130K.
See the evidence
This period
$530K (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
$130K
Typical spread (median absolute deviation)
$30K
How far from its usual level
+9.0
Same quarter last year
$300K
History used
4,201 days
the quarter ended 30 Sep 20248 earlier quartersnormal: $130K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
spent $21.7M on capital projects in the quarter ended 31 Mar 2024, 2.3× the same quarter last year.
Same quarter last year: $9.3M; its normal quarter is $7.8M.
See the evidence
This period
$21.7M (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
$7.8M
Typical spread (median absolute deviation)
$1.9M
How far from its usual level
+5.0
Same quarter last year
$9.3M
History used
5,296 days
the quarter ended 31 Mar 20248 earlier quartersnormal: $7.8M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
reported $300K of lobbying spend for the quarter ended 30 Sep 2023, 2.5× the same quarter last year.
Same quarter last year: $120K; its normal quarter is $105K.
See the evidence
This period
$300K (the quarter ended 30 Sep 2023)
Normal quarter (median of 8 earlier)
$105K
Typical spread (median absolute deviation)
$15K
How far from its usual level
+8.8
Same quarter last year
$120K
History used
3,835 days
the quarter ended 30 Sep 20238 earlier quartersnormal: $105K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
saw 46 13F filers open a new position in the quarter ended 30 Jun 2022, 3.3× the same quarter last year.
Same quarter last year: 14; its normal quarter is 21.5.
See the evidence
This period
46 (the quarter ended 30 Jun 2022)
Normal quarter (median of 8 earlier)
21.5
Typical spread (median absolute deviation)
4
How far from its usual level
+4.1
Same quarter last year
14
History used
1,826 days
the quarter ended 30 Jun 20228 earlier quartersnormal: 21.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
reported revenue of $365.6M for the quarter ended 31 Mar 2022, 1.3× the same quarter last year.
Same quarter last year: $280.7M; its normal quarter is $276.1M.
See the evidence
This period
$365.6M (the quarter ended 31 Mar 2022)
Normal quarter (median of 8 earlier)
$276.1M
Typical spread (median absolute deviation)
$8.9M
How far from its usual level
+3.2
Same quarter last year
$280.7M
History used
4,565 days
the quarter ended 31 Mar 20228 earlier quartersnormal: $276.1M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
reported revenue of $371.2M for the quarter ended 31 Dec 2021, 1.3× the same quarter last year.
Same quarter last year: $283.1M; its normal quarter is $269.9M.
See the evidence
This period
$371.2M (the quarter ended 31 Dec 2021)
Normal quarter (median of 8 earlier)
$269.9M
Typical spread (median absolute deviation)
$10.5M
How far from its usual level
+3.8
Same quarter last year
$283.1M
History used
4,475 days
the quarter ended 31 Dec 20218 earlier quartersnormal: $269.9M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Showing the newest 40 of 130 entries; narrow the window or the kind of data to see older ones.
Not listed: 268 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0000730464
Ticker
CVSA
Domain
covista.com
Employer name
Adtalem Global Education Inc., Covista Inc. (2 unverified)
Fein
36-3150143 (1 unverified)
Hq location
IL|CHICAGO|60606 (1 unverified)
Lobbying client
adtalem global education formerly devry education group, covista, covista formerly known as adtalem global education, devry education group
Name
Adtalem Global Education Inc., Covista Inc., DEVRY EDUCATION GROUP INC., DEVRY INC and 1 more
Uei
K3MWSYEG32U5
Wikidata
Q5244154
Wikipedia
Covista
DOL H-1B labor condition applications and PERM certifications32 data points8 Dec 2025 to 14 Sep 2026
Federal lobbying disclosures (LDA)11 records, 165 data points1 Mar 2013 to 30 Sep 2026
SEC Form 13F institutional holdings342 data points30 Jun 2017 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)180 records4 Feb 2016 to 29 Oct 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1062 data points30 Jun 2008 to 23 Oct 2026
SEC Form 4 insider transactions165 records, 520 data points25 Feb 2016 to 9 Oct 2026
FINRA short interest (twice monthly)51 data points27 Feb 2026 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)378 data points24 Feb 2026 to 20 Nov 2026
USASpending.gov federal awards9 records, 841 data points2 Oct 2007 to 4 Nov 2026
Wikipedia pageviews251 data points16 Mar 2026 to 21 Nov 2026